Glenmede Trust’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-219
Closed -$6K 1907
2020
Q3
$6K Sell
219
-7
-3% -$217 ﹤0.01% 2052
2020
Q2
$7K Sell
226
-84
-27% -$2.79K ﹤0.01% 1993
2020
Q1
$14K Hold
310
﹤0.01% 2263
2019
Q4
$14K Sell
310
-41
-12% -$1.93K ﹤0.01% 2263
2019
Q3
$18K Sell
351
-287
-45% -$14.8K ﹤0.01% 2094
2019
Q2
$32K Sell
638
-19
-3% -$1.01K ﹤0.01% 1888
2019
Q1
$36K Buy
657
+42
+7% +$2.36K ﹤0.01% 1837
2018
Q4
$31K Buy
+615
New +$35K ﹤0.01% 1796
2018
Q3
Sell
-251
Closed -$14K 1704
2018
Q2
$14K Buy
251
+30
+14% +$1.71K ﹤0.01% 1805
2018
Q1
$12K Hold
221
﹤0.01% 2129
2017
Q4
$12K Hold
221
﹤0.01% 2129
2017
Q3
$10K Buy
221
+202
+1,063% +$9.51K ﹤0.01% 2180
2017
Q2
$0 Hold
19
﹤0.01% 2679
2017
Q1
$0 Hold
19
﹤0.01% 2725
2016
Q4
$0 Sell
19
-25
-57% -$949 ﹤0.01% 2569
2016
Q3
$1K Buy
44
+25
+132% +$1.12K ﹤0.01% 2490
2016
Q2
$0 Sell
19
-298
-94% -$13K ﹤0.01% 2658
2016
Q1
$12K Buy
317
+92
+41% +$3.61K ﹤0.01% 1987
2015
Q4
$8K Hold
225
﹤0.01% 2140
2015
Q3
$7K Buy
225
+155
+221% +$5.52K ﹤0.01% 2205
2015
Q2
$2K Buy
+70
New +$2.41K ﹤0.01% 2447

Other funds holding OFIX

Glenmede Trust's OFIX Position: Q4 2020 in Review

Glenmede Trust sold out of Orthofix Medical (OFIX) in Q4 2020, closing a stake of 219 shares — an estimated $6K sold.

Glenmede Trust first reported a position in OFIX in Q2 2015 and held it in 21 quarters. The position peaked at $36K in Q1 2019. 141 funds tracked by Wall St. Rank hold OFIX as of Q4 2020.

  • Glenmede Trust reported no remaining Orthofix Medical position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 219 Orthofix Medical shares in Q4 2020, an estimated $6K.
  • Glenmede Trust first reported a position in Orthofix Medical in Q2 2015 and held it in 21 quarters.
  • Glenmede Trust's Orthofix Medical position peaked at $36K in Q1 2019.
  • 141 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.